Angiogenesis

Angiogenesis is the intricate biological process responsible for the formation of new blood vessels. Originating from pre-existing vessels, angiogenesis plays a pivotal role in a myriad of physiological and pathological events. While essential for processes such as wound healing and embryonic development, angiogenesis is also implicated in the growth and progression of malignant tissues, thus emerging as a focal point in cancer research.

Angiogenesis

Error creating thumbnail:

Wound healing phases

Physiological Role of Angiogenesis

EGFR signaling pathway

Blood vessels serve as the lifelines for tissue, providing essential nutrients and oxygen. The formation of these vessels, through angiogenesis, is critical during:

• Embryonic Development: The vascular system's formation is reliant on angiogenesis to establish a functional circulatory network.
• Wound Healing: Angiogenesis aids in the restoration of blood flow to injured tissues, facilitating healing.
• Menstrual Cycle: The endometrial layer undergoes regular cycles of proliferation, differentiation, and shedding, necessitating angiogenesis for support.

Angiogenesis in Pathology

While angiogenesis underpins essential physiological processes, aberrant angiogenesis can contribute to disease states, including:

• Cancer: Rapidly growing tumors require nutrients and oxygen. Tumor angiogenesis facilitates this, allowing malignant growth and potential metastasis. Anti-angiogenic therapies have thus emerged as a strategy in cancer treatment.
• Ocular Diseases: Conditions like age-related macular degeneration and diabetic retinopathy manifest due to abnormal blood vessel growth in the retina.
• Rheumatoid arthritis: Excessive angiogenesis in synovial tissues contributes to joint damage.

Mechanism of Angiogenesis

The equilibrium between pro-angiogenic and anti-angiogenic molecules determines angiogenesis. Factors such as vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) promote angiogenesis, while thrombospondin-1 and angiostatin work antagonistically.

• Initiation: Hypoxic conditions, as seen in growing tumors, trigger the release of pro-angiogenic factors like VEGF.
• Migration and Proliferation: Endothelial cells from existing vessels begin to proliferate and migrate towards the angiogenic stimuli.
• Maturation: With the guidance of supporting cells, like pericytes, the new vessels mature and stabilize.
• Inhibition: After serving their purpose, angiogenic processes recede under the influence of anti-angiogenic factors.

Therapeutic Potential

Considering angiogenesis's centrality in various diseases, targeting its pathways offers therapeutic avenues:

• Anti-Angiogenic Therapies in Cancer: Drugs like bevacizumab target VEGF, aiming to starve tumors of their blood supply.
• Ocular Therapies: Anti-angiogenic treatments can mitigate vision loss in conditions like macular degeneration.
• Tissue Engineering: Promoting angiogenesis is essential when designing grafts or implants to ensure their integration and survival.

Concluding Remarks

Angiogenesis, while a fundamental physiological process, bears significant pathological implications, especially concerning malignancies. By unraveling its intricate mechanisms, potential therapeutic strategies continue to evolve, offering hope in combating diseases marked by aberrant blood vessel growth.

Professions:Medicine | Nursing | Pharmacy | Healthcare science | Dentistry | Allied health professions | Healthcare

Angiogenesis Resources
Latest articles Most recent articles Ongoing trials	Wikipedia